EDMONTON, Feb. 6, 2020 /CNW/ – PRESS RELEASE – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this... Read more

EDMONTON, Feb. 6, 2020 /CNW/ – PRESS RELEASE – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this... Read more

EDMONTON, Feb. 6, 2020 /CNW/ – PRESS RELEASE – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this... Read more

New Hampshire lawmakers have again launched cannabis legalization efforts this year, this time taking a criminal justice approach to the issue. H.B. 1648 would legalize the possession and limited home cultivation of cannabis for adults 21 and older, and may be more palatable to lawmakers than past legislation aimed... Read more

Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

EDMONTON, Feb. 6, 2020 /CNW/ – PRESS RELEASE – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this... Read more

Colorado State University (CSU) has received a sizeable donation from an alumna to create a research center dedicated to studying the chemical compounds in hemp. The research center, located in the College of Natural Sciences on CSU’s Fort Collins campus, is focused on developing an analytical research lab that... Read more